Single-Stage Acellular Scaffold Delivers Tenfold Hyaline Cartilage Growth Over Microfracture
This technology provides a 3D-printed, bioactive scaffold that recruits patient stem cells to regenerate joint cartilage during microfracture surgery, alongside a specialized centrifugal testing device for isolating and evaluating cells attached to the scaffold.
Background
Articular cartilage lines the ends of bones in joints, enabling frictionless movement and absorbing mechanical shock. Unlike bone, this tissue lacks a direct blood supply and contains very few resident cells, giving it an extremely limited capacity to heal itself after trauma, sports injuries, or degenerative diseases. Untreated cartilage defects can progress to osteoarthritis and eventual joint replacement, and current surgical treatments introduce significant clinical hurdles.
Microfracture is a widely used technique that involves drilling holes into the underlying bone to release the patient’s own stem cells into the defect site. However, without structural guidance or biological cues to trap and direct these cells, microfracture produces scar tissue that lacks the resilience of healthy cartilage and breaks down over time.
Conversely, more advanced cell-based therapies require harvesting a patient’s cells, and standard synthetic implants fail to replicate the internal architecture of natural tissue and lack the biological signaling needed to recruit stem cells effectively.
Technology
This patented 3D-printed, cell-free polymer scaffold repairs damaged joint cartilage during microfracture surgery. Fabricated from a biodegradable polymer blend, it is printed in three distinct layers with parallel, crosshatched, and perpendicular fibers to mimic the layered structure of natural cartilage, and can include an interlocking base for bone integration. After printing, the surface is chemically bonded with aggrecan, a key cartilage protein.
The cartilage implant is fabricated in a layer-by-layer fashion via extrusion-based 3D printing, starting from a CAD model that can be either designed or directly generated from imaging data routinely collected in the clinics (e.g. MRI, CAT scan). The material is extruded according to 3 different layer patterns designed to guide the growth and differentiation of resident stem cells according to the 3 different zone observed in native cartilage.
This technology offers an off-the-shelf implant that regenerates durable tissue in a single surgery. The scaffold’s aggrecan coating and layered architecture actively capture the body’s own stem cells and growth factors directly at the injury site. Compared to standard treatments, it increases stem cell attachment and type II collagen production tenfold, guiding the growth of thick, healthy cartilage that restores joint mobility.
Benefits
-
Enables single-stage surgical repair using an off-the-shelf, acellular scaffold, eliminating the need for multi-stage surgeries and in vitro cell expansion
-
Enhances recruitment and adhesion of endogenous mesenchymal stem cells at the defect site via covalently immobilized aggrecan
-
Promotes the regeneration of durable, hyaline-like cartilage with significantly increased tissue thickness, glycosaminoglycan deposition, and type II collagen production compared to traditional microfracture
-
Mimics the hierarchical organization and mechanical compliance of native articular cartilage through a customizable, 3D-printed zonal pore architecture
-
Adapts to patient-specific defect geometries using medical imaging data and supports full-thickness osteochondral repair via interlocked bone-to-cartilage material transitions
-
Improves post-operative functional recovery, joint alignment, and locomotor performance without inducing aberrant subchondral bone remodeling
Applications
- Articular cartilage regeneration implants
- Microfracture surgery augmentation scaffolds
- Patient-specific osteochondral defect repair
- Veterinary joint cartilage restoration
- In vitro cell adhesion assays